MODULE 3 MEDICATIONS Flashcards
(58 cards)
1
Q
CLASSIFICATION
ADENOSINE
A
- ANTIDYSRHYTHMIC AGENT
2
Q
DOSAGE
ADULT
ADENOSINE
A
- FIRST DOSE: 6 MG RAPID IV/IO
- SECOND DOSE: 12 MG RAPID IV/IO
3
Q
DOSAGE
PEDIATRIC
ADENOSINE
A
- FIRST DOSE: 0.1MG/KG IV/IO MAX 6MG
- SECOND DOSE: 0.2MG/KG MAX 12MG
4
Q
INDICATION
ADENOSINE
A
- SVT/PSVT
- WIDE COMPLEX - REGULAR TACHYCARDIA OF UNKNOWN ORIGIN (DIAGNOSTIC TREATMENT)
5
Q
CONTRAINDICATION
ADENOSINE
A
- CONFIRMED V-TACH, A-FIB, A-FLUTTER
- KNOWN HYPERSENSITIVITY
- WPW
6
Q
ADVERSE EFFECTS
ADENOSINE
A
- FEELING OF IMPENDING DOOM
- SHORTNESS OF BREATH
- CHEST PRESSURE
- HYPOTENSION
- FLUSHING
- DIZZINESSS
- NAUSEA
- HEADACHE
7
Q
CLASSIFICATION
AMIODARONE
A
- ANTIARRHYTHMIC
8
Q
DOSAGE
V-FIB/PULSELESS VT
AMIODARONE
A
- FIRST DOSE: 300MG IV/IO (DILUTED IN 20-30ML D5W)
- SECOND DOSE: 150MG (DILUTED IN 20-30ML D5W)
- MAX TOTAL BOLUS 450M
9
Q
DOSAGE
WIDE COMPLEX TACHYCARDIA W/PULSE
AMIODARONE
A
- 150MG IV/IO DILUTED IN 50-100ML OVER 10 MIN
10
Q
DOSAGE
MAINTANANCE INFUSION
AMIODARONE
A
- 1MG/MIN
- 100MG IN 100ML D5W
11
Q
INDICATION
AMIODARONE
A
- V-TACH (WITH & WITHOUT PULSE)
- V-FIB
- REFRACTORY V-TACH
12
Q
CONTRAINDICATION
AMIODARONE
A
- CARDIOGENIC SHOCK
- HIGH DEGREE HEART BLOCK (2 MOBITZ II & 3)
- IODINE ALLERGY
- NONE IN CARDIAC ARREST
- SA NODE DISFUCTIONS
13
Q
ADVERSE EFFECTS
AMIODARONE
A
- BRADYCARDIA
- CONGESTIVE HEART FAILURE
- HYPOTENSION
- NAUSEA
- VOMITING
14
Q
CLASSIFICATION
ATROPINE
A
- PARASYMPATHOLYTIC
- ANTICHOLINERGIC
15
Q
DOSAGE
ADULT BRADYCARDIA
ATROPINE
A
- 1MG IV/IO/ET
- EVERY 3-5MIN
- MAX DOSE OF 3MG
16
Q
DOSAGE
PEDIATRIC BRADYCARDIA
ATROPINE
A
- 0.02 MG/KG IV/IO/ET
- MINIMUM DOSE 0.1MG
17
Q
DOSAGE
ADULT ORGANOPHOSPHATE POISONING
ATROPINE
A
- 1-4MG IV/IO/ET/IM
- EVERY 5-10 UNTIL ATROPINIZATION OCCURS
18
Q
INDICATION
ATROPINE
A
- SYMPTOMATIC BRADYCARDIA
- ORGANOPHOSPHATE POISONING
- NERVE AGENT POISONING
19
Q
CONTRAINDICATION
ATROPINE
A
- DYSRHYTHMIAS THAT ACCELERATE VENTRICULAR RATE AND DECREASE CARDIAC OUTPUT
- EXAMPLES: A-FIB, A-FLUTTER, PAT W/ BLOCK
20
Q
ADVERSE EFFECTS
ATROPINE
A
- ATAXIA
- BLURRED VISION
- COMA
- DELERIUM
- DISORIENTATION
- RESTLESSNESS
- TACHYCARDIA
21
Q
CLASSIFICATION
DILTAZEM (CARDIZEM)
A
- CALCIUM CHANNEL BLOCKER
- ANTIDYSRHYTHMIC
22
Q
DOSAGE
DILTAZEM (CARDIZEM)
A
- INITAL: 0.25MG/KG IV/IO OVER 5MIN (MAX 20MG)
- REPEAT IN 15MIN: O.35MG/KG IV/IO OVER 5MIN (MAX 25MG)
- MAINTENANCE INFUSION: 5-15MG/HR
23
Q
INDICATION
DILTAZEM (CARDIZEM)
A
- STABLE UNCONTROLLED A-FIB/A-FLUTTER WITH SUSTAINED RATES >120BPM
- SECOND LINE MEDICATION FOR STABLE REGULAR-NARROW COMPLEX TACHYDYSRHTHMIAS (SVT/PSVT)
24
Q
CONTRAINDICATION
DILTAZEM (CARDIZEM)
A
- HEART FAILURE
- HIGH DEGREE HEART BLOCK (2nd DEGREE: II or 3rd DEGREE)
- HYPOTENSION
- SHOCK
- V-TACH
25
ADVERSE EFFECTS
| DILTAZEM (CARDIZEM)
* DYSRHTHMIAS
* HEADACHES
* HYPOTENSION
* NAUSEA
* VOMITING
26
CLASSIFICATION
| DOPAMINE
* INOTROPIC AGENT
* SYMPATHOMIMETIC
* VASOPRESSOR
27
DOSAGE
ADULT
| DOPAMINE
* 5-20 MCG/KG/MIN IV DRIP TITRATED TO SYSTOLIC BP OF 0F 90
* INITIAL DOSE OF 5MCG/KG/MIN
28
DOSAGE
PEDIATRIC
| DOPAMINE
* 2-20 MCG/KG/MIN IV DRIP TITRATED TO AGE SPECIFIC SYSTOLIC BP
* INITIAL RATE OF 2 MCG/KG/MIN
29
INDICATION
| DOPAMINE
* CARDIOGENIC SHOCK
* SHOCK (ALL ETIOLOGIES)
* SYMPTOMATIC BRADYCARDIA (AFTER ATROPINE ADMINISTRATION)
30
CONTRAINDICATION
| DOPAMINE
* PRE-EXISTING TACHYDYSRHTHMIAS
* UNCORRECTED HYPOVOLEMIA
31
ADVERSE EFFECTS
| DOPAMINE
* ANGINAL PAIN
* HYPERTENSION
* TACHYDYSRHTHMIAS
* NAUSEA
* VOMMITING
32
CLASSIFICATION
| LIDOCANE
* ANTIDYSRHTMIC
* SODIUM CHANNEL BLOCKER
33
DOSAGE
ADULT VT W/PULSE
| LIDOCANE
* 0.5 -1.5 MG/KG IV/IO MAX 3MG/KG
* REPEAT DOSES ARE HALF OF INITIAL DOSE
34
DOASGE
ADULT VT/VF W/O PULSE
| LIDOCANE
* 1-1.5 MG/KG IV/IO BOLUS
* REPEAT EVERY 5-10MIN
* MAX 3MG/KG
* REPEAT DOSES ARE HALF OF INITIAL DOSE
35
DOSAGE
PEDIATRIC VT WITH/WITHOUT PULSE
| LIDOCANE
* 1MG/KG IV/IO
* EVERY 5-10MIN
* MAX 3MG/KG
36
DOSAGE
ADULT IO ADMIN FOR NUMBING
| LIDOCANE
* 20 - 40 MG SLOW IO PUSH
37
INDICATION
| LIDOCANE
* V-TACH WITH/WITHOUT PULSLE
* V-FIB
* IO NUMBING
* DECREASE INTREACRANIAL PRESSURE WITH RSI
* REDUCE ERADIC VENTRICULAR ECTOPY
38
CONTRAINDICATION
| LIDOCANE
* ACCELERATED IDIOVENTRICULAR RHYTHMS
* AV BLOCK
* IDIOVENTRICULAR ESCAPE RHYTHEMS
* SINUS- BRADY/ARREST/BLOCK
* STOKE-ADAM SYNDROME
* WOLFF-PARKINSON-WHITE (WPW)
39
ADVERSE EFFECTS
(TOXICITY)
| LIDOCANE
* MAY CAUSE CLINICAL EVIDENCE OF TOXICITY
* EARLY SIGNS:
- ALTERED MENTAL STATUS
- ANXIETY
- BRADYCARDIA
- TROUBLE BREATHING
- NAUSEA
* LATE SIGNS:
- COMA
- WIDENING OF QRS COMPLEX
- HALLUCINATIONS
- HEARING LOSS
- PROLONGED P-R INTERVAL
40
CLASSIFICATION
| METOPROLOL
* BETA BLOCKER
41
DOSAGE
| METOPROLOL
* 5MG IVP OVER 5MIN
* REPEAT EVERY 5
42
INDICATION
| METOPROLOL
* A-FIB/A-FLUTTER WITH SUSTAINED RATE OVER 120BPM
* ACUTE CORONARY SYNDROME ASSOCIATED W/STEMI TACHYCARDIA
* REFRACTORY PSVT/SVT
43
CONTRAINDICATION
| METOPROLOL
* ASTHMA ATTACK OR COPD EXACERBATION
* SYSTOLIC LESS THAN 90
* HR LESS THAN 100
* HIGH DEGREE HEART BLOCK (2ND OR 3RD DEGREE AV BLOCK)
* SHOCK
44
ADVERSE EFFECTS
| METOPROLOL
* CHF
* CNS CHANGES
* DYSRYTHMIAS
* HYPOTENSION
* NAUSEA
* VOMITING
45
CLASSIFICATION
| VERAPAMIL
* CALCIUM CHANNEL BLOCKER
* ANTIDYSRHYTHMIC
46
DOSAGE
| VERAPAMIL
* INITIAL: 2.5-5MG IV/IO OVER 2 MIN
* REPEAT: 5-10MG IN 15-30MIN
* MAX OF 20MG
47
INDICATION
| VERAPAMIL
* STABLE UNCONTROLLED A-FLUTTER OR FIBRILATION WITH RVR
* SECOND LINE MEDICATION FOR STABLE NARROW COMPLEX TACHYDYSRHYTHMIAS (PSVT/SVT)
48
CONTRAINDICATION
| VERAPAMIL
* HEART FAILURE
* HIGH DEGREE HEART BLOCK
* HYPERSENSITIVITY
* V-TACH
* SHOCK
* WPW
* SICK SINUS SYNDROME
49
ADVERSE EFFECTS
| VERAPAMIL
* HEADACHES
* HYPOTENSION
* DYSRHYTHMIAS
* NAUSEA
50
CLASSIFICATION
| EPINEPHRINE
* ADRENERGIC CATECHOLAMINE
* SYMPATHOMIMETIC (VASOPRESSOR)
51
DOSAGE
ADULT CARDIAC ARREST
| EPINEPHRINE
* 1MG (1:10,000) IV/IO
* EVERY 3-5MIN
52
DOSAGE
PEDIATRIC CARDIAC ARREST
| EPINEPHRINE
* 0.01MG/KG (1:10,000) IV/IO EVERY 3-5MIN
53
DOSAGE
ROSC
| EPINEPHREN
* 0.1 - 0.5 MCG/KG/MIN
* STANDARD CONCENTRATION = 1MG EPI/250ML NS
54
DOSAGE
SYMPTOMATIC (UNSTABLE) BRADYCARDIA ADULT
| EPINEPHREN
* 2-10 MCG/MIN
* 1MG EPI IN 250ML D5W
55
DOSAGE
SYMPTOMATIC (UNSTABLE) BRADYCARDIA PEDIATRIC
| EPINEPHREN
* 0.01MG/KG (1:10,000) IV/IO
* REPEAT EVERY 3-5MIN
56
INDICATION
| EPINEPHRINE
* CARDIAC ARREST
* ROSC
* SYMPTOMATIC BRADYCARDIA
* ANAPHYLAXIS
* BRONCHIAL ASTHMA
* STRIDOR
57
CONTRAINDICATION
| EPINEPHRINE
* HYPERTENSION
* NONE IN CARDIAC SETTING
58
ADVERSE EFFECTS
| EPINEPHRINE
* TACHYDYSRHYTHMIAS
* HYPERTENSION
* HEADACHE
* TREMORS
* NERVOUSNESS
* REBOUND EDEMA
* MAY INDUCE EARLY LABOR IN PREGNANT WOMEN
